NCT02760498 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 63
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 167
- group Id
- BG006
- value
- 432
- units
- Participants
- groups
- description
- Participants received cemiplimab 3 milligrams (mg)/kilogram (kg) intravenously (IV) every 2 weeks (Q2W) during each 8-week treatment cycle, for up to 96 weeks (12 cycles).
- id
- BG000
- title
- Group 1 (Participants With mCSCC): Cemiplimab 3 mg/kg IV Q2W
- description
- Participants received cemiplimab 3 mg/kg IV Q2W during each 8-week treatment cycle, for up to 96 weeks (12 cycles).
- id
- BG001
- title
- Group 2 (Participants With laCSCC): Cemiplimab 3 mg/kg IV Q2W
- description
- Participants received cemiplimab 350 mg IV every 3 weeks (Q3W) during each 9-week treatment cycle, for up to 54 weeks (6 cycles).
- id
- BG002
- title
- Group 3 (Participants With mCSCC): Cemiplimab 350 mg IV Q3W
- description
- Participants received cemiplimab 600 mg IV every 4 weeks (Q4W) during each 8-week treatment cycle, for up to 48 weeks (6 cycles).
- id
- BG003
- title
- Group 4 (Participants With mCSCC and laCSCC): Cemiplimab 600 mg IV Q4W
- description
- Participants received a single 438 mg subcutaneous (SC) dose of cemiplimab followed by cemiplimab 350 mg IV Q3W during each 9-week treatment cycle, for up to 54 weeks (6 cycles).
- id
- BG004
- title
- Group 5 (Participants With mCSCC and laCSCC): Cemiplimab 438 mg SC + 350 mg IV Q3W
- description
- Participants received cemiplimab 350 mg IV Q3W during each 9-week treatment cycle, for up to 108 weeks (12 cycles).
- id
- BG005
- title
- Group 6 (Participants With mCSCC and laCSCC): Cemiplimab 350 mg IV Q3W
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 30
- group Id
- BG006
- value
- 98
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 43
- group Id
- BG006
- value
- 130
- title
- >= 65 to < 75 years
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 94
- group Id
- BG006
- value
- 204
- title
- >= 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 37
- group Id
- BG006
- value
- 83
- title
- Female
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 53
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 130
- group Id
- BG006
- value
- 349
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 55
- group Id
- BG003
- value
- 62
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 147
- group Id
- BG006
- value
- 405
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 16
- group Id
- BG006
- value
- 18
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 7
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 61
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 164
- group Id
- BG006
- value
- 420
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- The Full Analysis Set (FAS) included all enrolled participants.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 56
- group Id
- BG003
- value
- 63
- group Id
- BG004
- value
- 9
- group Id
- BG005
- value
- 167
- group Id
- BG006
- value
- 432
- units
- Participants
- groups
- description
- Participants received cemiplimab 3 milligrams (mg)/kilogram (kg) intravenously (IV) every 2 weeks (Q2W) during each 8-week treatment cycle, for up to 96 weeks (12 cycles).
- id
- BG000
- title
- Group 1 (Participants With mCSCC): Cemiplimab 3 mg/kg IV Q2W
- description
- Participants received cemiplimab 3 mg/kg IV Q2W during each 8-week treatment cycle, for up to 96 weeks (12 cycles).
- id
- BG001
- title
- Group 2 (Participants With laCSCC): Cemiplimab 3 mg/kg IV Q2W
- description
- Participants received cemiplimab 350 mg IV every 3 weeks (Q3W) during each 9-week treatment cycle, for up to 54 weeks (6 cycles).
- id
- BG002
- title
- Group 3 (Participants With mCSCC): Cemiplimab 350 mg IV Q3W
- description
- Participants received cemiplimab 600 mg IV every 4 weeks (Q4W) during each 8-week treatment cycle, for up to 48 weeks (6 cycles).
- id
- BG003
- title
- Group 4 (Participants With mCSCC and laCSCC): Cemiplimab 600 mg IV Q4W
- description
- Participants received a single 438 mg subcutaneous (SC) dose of cemiplimab followed by cemiplimab 350 mg IV Q3W during each 9-week treatment cycle, for up to 54 weeks (6 cycles).
- id
- BG004
- title
- Group 5 (Participants With mCSCC and laCSCC): Cemiplimab 438 mg SC + 350 mg IV Q3W
- description
- Participants received cemiplimab 350 mg IV Q3W during each 9-week treatment cycle, for up to 108 weeks (12 cycles).
- id
- BG005
- title
- Group 6 (Participants With mCSCC and laCSCC): Cemiplimab 350 mg IV Q3W
- description
- Total of all reporting groups
- id
- BG006
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 16
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 30
- group Id
- BG006
- value
- 98
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 17
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 43
- group Id
- BG006
- value
- 130
- title
- >= 65 to < 75 years
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 30
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 94
- group Id
- BG006
- value
- 204
- title
- >= 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 37
- group Id
- BG006
- value
- 83
- title
- Female
- measurements
- group Id
- BG000
- value
- 54
- group Id
- BG001
- value
- 59
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 53
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 130
- group Id
- BG006
- value
- 349
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 55
- group Id
- BG003
- value
- 62
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 147
- group Id
- BG006
- value
- 405
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 16
- group Id
- BG006
- value
- 18
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 7
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 75
- group Id
- BG002
- value
- 54
- group Id
- BG003
- value
- 61
- group Id
- BG004
- value
- 8
- group Id
- BG005
- value
- 164
- group Id
- BG006
- value
- 420
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- The Full Analysis Set (FAS) included all enrolled participants.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle